What will the 2018 Southern Hemisphere Flu Vaccine include?
What will the 2018 Southern Hemisphere Flu Vaccine include?
Canberra. October 11, 2017
The Australian Influenza Vaccine Committee (AIVC) congregated at the Therapeutic Goods Administration (TGA) to recommend influenza viruses be used in the composition of the 2018 flu vaccine. The meeting involved the review and evaluation of:
- data associated with epidemiology
- Australia and Southern Hemisphere influenza isolates recently circulating, as to its antigenic and genetic characteristics
- 2016-17 vaccines' serological responses
- candidate vaccine viruses and reagents availability
- The expert committee recommended that the TGA adopt 2017 September 28th's World Health Organisation (WHO) recommendation for the 2018 Southern Hemisphere influenza vaccines.
What will the 2018 Flu Vaccine include?
- Trivalent influenza vaccine components should contain three strains, namely-
- A (H1N1) - an A/Michigan/45/2015 pdm09-like virus.
- A (H3N2) - an A/Singapore/INFIMH-16-0019/2016 -like virus.
- B - a B/Phuket/3073/2013-like virus.
- Quadrivalent influenza vaccines should contain the trivalent influenza vaccine, with a second B strain added, making a total of four components.
- A (H1N1) - an A/Michigan/45/2015 pdm09-like virus.
- A (H3N2) - an A/Singapore/INFIMH-16-0019/2016 -like virus.
- B - a B/Phuket/3073/2013-like virus.
- B - a B/Brisbane/60/2008-like virus.
A side-by-side comparison of 2017 trivalent and quadrivalent vaccine compositions shows the difference in the introduction of a new A (H3N2) like virus constituent. For the Trivalent, the B/Brisbane strain was swapped with the B/Phuket strain included in the Quadrivalent vaccine. The 2018 AIVC recommendations were accepted by the TGA.
In line with the latest research and recommendations, Corporate Care will only administer Quadrivalent vaccines in its 2018 Flu Vaccination programs towards optimal year-round protection.
Let's chat!
- Behind the Syringe
- Flu Insights
Introducing Aitor Aspiazu, your go-to flu expert and a Registered Nurse accredited by AHPRA (NMW0001159845). Boasting over two decades of experience in healthcare, Aitor has navigated everything from Emergency Departments to Corporate Wellness Programs—and yes, he’s even battled the flu himself. As the Founder and Lead Nurse Consultant at Corporate Care, he’s the driving force behind workplace health and well-being. No longer in scrubs, he’s now at the forefront of healthcare innovation, leveraging Artificial Intelligence and automation to revolutionise workplace health and well-being. As the Founder and Lead Nurse Consultant at Corporate Care, he’s the visionary behind cutting-edge flu vaccination programs that keep businesses running smoothly. Off-duty, he’s a proud dad and a Padel addict who represented Australia in the World Padel Championship. Trust Aitor; he’s got your back when it comes to flu prevention and modern healthcare solutions.